Penserra Capital Management LLC bought a new position in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,104 shares of the biotechnology company’s stock, valued at approximately $211,000. Several other […]
Prothena (NASDAQ:PRTA – Get Free Report) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Monday. A number of other analysts have also commented on PRTA. Cantor Fitzgerald reiterated an “overweight” rating and issued a $129.00 price target on shares of Prothena in a […]
Shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) have received a consensus rating of “Moderate Buy” from the nine brokerages that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month […]